MRK

NYSE 已收盘

Merck & Co., Inc.

128.00 USD
+0.41+0.18%
盘后 130.70 +0.38%
2026-07-31
市值
$316.14B
市盈率
100.56
EPS
3.58
股息率
2.61%
52 周区间
77.53 – 135.05
成交量
11.82M
Beta
0.20
目标价
135.19
52W 低 77.5352W 高 135.05
价格走势

公司简介

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock produ...

关联新闻